Actively Recruiting
Study to Understand Differences in Opioid Withdrawal Symptoms and Effects of Lofexidine-Assisted Opioid Tapering in Adults with Opioid Use Disorder
Led by University of Maryland, Baltimore · Updated on 2025-09-12
60
Participants Needed
1
Research Sites
12 weeks
Total Duration
AI-Summary
What This Trial Is About
This research aims to understand why people with opioid use disorder OUD show different withdrawal symptoms when tapering off opioids. The study evaluates withdrawal symptom patterns during medication tapering in individuals physically dependent on opioids. Researchers hope to improve current treatment approaches by learning how opioid withdrawal symptoms vary among patients. Participants will stay in a residential research unit for 11 days. For the first 5 days, they will receive morphine to stabilize withdrawal symptoms. During this time, they will have two sessions where naloxone injections trigger short withdrawal episodes before each session, they will take either a placebo or the opioid withdrawal medication lofexidine. From day 6 to day 10, participants will be tapered off morphine with lofexidine. On day 11, they will transition to standard care with either buprenorphine maintenance or oral naltrexone and an extended-release injection called Vivitrol. Throughout the study, researchers will collect biological samples and have participants complete questionnaires to measure withdrawal severity during naloxone challenges and the lofexidine taper. These data will help assess individual differences in withdrawal symptoms. The study includes close monitoring and aims to inform better treatment methods for opioid withdrawal. Participation lasts 11 days in total.
CONDITIONS
Brief Title
Assessing a Clinically-meaningful Opioid Withdrawal Phenotype
Research Team
K
Kelly E Dunn, Ph.D, M.B.A.
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here